still alive and kicking
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does Gil have a benefactor who will continue to string everyone along after he dies? I need that comfort .. lol. hi everyone, thought I would drop by and see how all of us bagholders are doing. take care
emailed with M. Low about a month ago and he confirmed they are still fighting this battle with Brazilian Govt.
Don't know a lot about Elon other than it is in a nice area. But, good luck with that, I know you will be glad when things are settled.
Yeah, especially if you pay in-State tuition. Sent my daughter to NCSU, the best school for the sciences and engineering in the State IMO. NCSU also doing some innovative research in alternative energy. Both my wife and I went there as well but no bias there ; ) . UNC is probably a better liberal arts university than State. Can't say too many good things about Chapel Hill or I will lose my stripes.
gl with your daughter ski, I'm in NC (near Winston-Salem - Wake Forest). Both Duke and Wake are good universities depending on what she wants to study. If the sciences, law, or international studies, I would lean heavily towards Duke. Otherwise, probably both are equal. Of course, u didn't ask for my opinion but I gave it to you anyway! Any questions I can answer about Winston, let me know, I've lived in and around it all my life.
rags
way to soften the blow double! lol
Hi guys! Any chance these useless shares will have value or do we need to cash them on for the tax loss this year? Any chance some company will take over gsii as a shell or is that even possible? You guys take care. Hope Jersey has gotten something for all his work. comrade in bagholders .. rags
Are we there yet?! .. lol eom
glad u put that in quotes!
Just remind me to rid myself of this worthless paper before the end of the year if it doesn't happen. Forgot last year and didn't get the tax loss benefits. At least there is that.
Yes, he needs to turn this over to someone else. His mind is seems unable to comprehend the complicities of running a company any more, especially a public company. He hasn't seemed to learn a thing about giving overly optimistic projections of activities here. I think senility is kicking in hard and he isn't facing the realities of his later stage of life. It is either that or he is a big liar but I choose to give him the benefit of the doubt just because it makes life more pleasant with those rose colored glasses.
that's it in a nutshell
London Pacific & Partners, Inc. Reports Strong FY2009 Results with Positive 2010 Outlook
Brazil Acquisition Expected to Close in Q2 2010
Press Release Source: London Pacific & Partners, Inc. On Tuesday March 30, 2010, 7:00 am EDT
EL SEGUNDO, Calif.--(BUSINESS WIRE)--LONDON PACIFIC & PARTNERS, INC. (PINK SHEETS: LDPP - News) (“London Pacific” or the “Company”), the international investment and management advisor, today reported its full-year 2009 results, highlighted by a 55.2% and 29.7% increase in its 2009 revenues and operating profit, respectively, compared with 2008. The Company generated $1,950,897 in revenues and $706,059 in operating profit during 2009, compared to $1,257,216 and $544,222 in 2008, indicating significant advances in the Company’s strategic, operational, and financial advisory services. These results include the August to December 2009 financial performance of Acadia Group Advisors, Inc.
In August 2009, the Company completed both its acquisition of Acadia Group Advisors, Inc., a privately-held international corporate financier and private equity advisor, and a profit sharing arrangement with Harrell Hospitality Group, LLC, an established hotel management and investment firm.
London Pacific Executive Chairman Stuart Bruck said that in 2009 the Company made continued, measurable progress in moving the Company forward, noting, “Our strong financial results during the year were led by a solid performance from its Healthcare Advisory Services, London & Pacific Capital Advisors, LLC, and Acadia Group Advisors, Inc., which each had several successful engagements during 2009.
“For 2010, with the recent agreement to acquire the Ana Costa healthcare system in Brazil and continuing expansion into the hospitality and financial services sector, we will continue to focus on strengthening the company and building shareholder value.”
Regarding the acquisition of Ana Costa, a private regional healthcare system with a 125,000-member health maintenance organization (HMO), three hospitals with a total of 290 beds, three full-service clinics and related interests, Mr. Bruck stated, “We are currently expecting the approval of the transfer of the licenses by the Brazilian authorities and other conditions of closing to be met sometime in Q2 of 2010.”
About London Pacific & Partners, Inc.:
With offices in Los Angeles, Salt Lake City, London and Mumbai, London Pacific & Partners, Inc. is an international private equity and corporate finance investor and advisor focused on the transformation of undervalued and growth companies in the healthcare, hospitality, and financial services sectors. The Company’s website address is http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.londonpacificgroup.com&esheet=6231656&lan=en_US&anchor=www.londonpacificgroup.com&index=1&md5=10ebfe2c6a28c1ebfed34bfaca40a44a.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, and the impact of competitive services and pricing and general economic risks and uncertainties.
Contact:
London Pacific & Partners, Inc.Michael Low310.531.8226info@LondonPacificGroup.com
LDPP - London Pacific & Partners, Inc. Reports Strong FY2009 Results with Positive 2010 Outlook
Brazil Acquisition Expected to Close in Q2 2010
Press Release Source: London Pacific & Partners, Inc. On Tuesday March 30, 2010, 7:00 am EDT
EL SEGUNDO, Calif.--(BUSINESS WIRE)--LONDON PACIFIC & PARTNERS, INC. (PINK SHEETS: LDPP - News) (“London Pacific” or the “Company”), the international investment and management advisor, today reported its full-year 2009 results, highlighted by a 55.2% and 29.7% increase in its 2009 revenues and operating profit, respectively, compared with 2008. The Company generated $1,950,897 in revenues and $706,059 in operating profit during 2009, compared to $1,257,216 and $544,222 in 2008, indicating significant advances in the Company’s strategic, operational, and financial advisory services. These results include the August to December 2009 financial performance of Acadia Group Advisors, Inc.
In August 2009, the Company completed both its acquisition of Acadia Group Advisors, Inc., a privately-held international corporate financier and private equity advisor, and a profit sharing arrangement with Harrell Hospitality Group, LLC, an established hotel management and investment firm.
London Pacific Executive Chairman Stuart Bruck said that in 2009 the Company made continued, measurable progress in moving the Company forward, noting, “Our strong financial results during the year were led by a solid performance from its Healthcare Advisory Services, London & Pacific Capital Advisors, LLC, and Acadia Group Advisors, Inc., which each had several successful engagements during 2009.
“For 2010, with the recent agreement to acquire the Ana Costa healthcare system in Brazil and continuing expansion into the hospitality and financial services sector, we will continue to focus on strengthening the company and building shareholder value.”
Regarding the acquisition of Ana Costa, a private regional healthcare system with a 125,000-member health maintenance organization (HMO), three hospitals with a total of 290 beds, three full-service clinics and related interests, Mr. Bruck stated, “We are currently expecting the approval of the transfer of the licenses by the Brazilian authorities and other conditions of closing to be met sometime in Q2 of 2010.”
About London Pacific & Partners, Inc.:
With offices in Los Angeles, Salt Lake City, London and Mumbai, London Pacific & Partners, Inc. is an international private equity and corporate finance investor and advisor focused on the transformation of undervalued and growth companies in the healthcare, hospitality, and financial services sectors. The Company’s website address is http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.londonpacificgroup.com&esheet=6231656&lan=en_US&anchor=www.londonpacificgroup.com&index=1&md5=10ebfe2c6a28c1ebfed34bfaca40a44a.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, and the impact of competitive services and pricing and general economic risks and uncertainties.
Contact:
London Pacific & Partners, Inc.Michael Low310.531.8226info@LondonPacificGroup.com
CEMI.ob .Chembio's DPP(R) Oral Fluid HIV Test Approved by USAID
Outstanding Performance vs. Leading Tests in International Study; U.S. Clinical Trials Commenced, Company Participating in U.S. HIV Testing Conference 3/24-26
Release Source: Chembio Diagnostics, Inc. On Wednesday March 24, 2010, 7:00 am EDT
MEDFORD, NY--(Marketwire - 03/24/10) - Chembio Diagnostics, Inc. (OTC.BB:CEMI - News), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced that its DPP® Oral HIV 1&2 Screen Assay for use with oral fluid or blood samples has been approved by the U.S. Agency for International Development ("USAID") for inclusion on the list of approved rapid HIV tests. This approval makes the test eligible for procurement with funds provided by the United States President's Emergency Plan for AIDS Relief, or PEPFAR. Recent international field studies, including one undertaken by the U.S. Centers for Disease Control Global AIDS Program ("CDC-GAP") on behalf of the USAID for purposes of this approval, indicate that the product's accuracy exceeds that of certain other rapid HIV tests that are widely used by PEPFAR. Chembio has initiated clinical trials in the United States for this product in connection with a planned United States Food & Drug Administration ("FDA") Pre-Marketing Approval ("PMA") application. The clinical trials are anticipated to be completed during 2010. This product and Chembio's DPP® Syphilis Screen & Confirm test will be exhibited at the HIV Diagnostics Conference that begins today in Orlando, Florida.
The DPP® Oral HIV 1&2 Screen Assay was recently evaluated by CDC-GAP in Mozambique, performing with 100% sensitivity and 99.8% specificity, a performance which exceeded that of each of the other three tests (two blood tests and one oral fluid test) that were included in the study, two of which are leading tests widely used by PEPFAR and other international HIV/AIDS programs. The CDC-GAP study involved 1674 patients (517 positive and 1157 negative). In a second study, sponsored by Chembio and conducted through the National Hospital in Abuja, Nigeria in which a total of 645 patients participated (223 positive and 422 negative), the Chembio DPP® oral fluid assay performed with 100% sensitivity and 100% specificity. These two international studies provide strong evidence of outstanding performance for this assay.
Chembio is now registering and establishing distribution for the DPP® oral fluid HIV test in developing world markets where there is expected demand for this unique product. Once Chembio receives the PMA approval currently anticipated to be during 2011, it intends to market the product through its own sales organization in order to provide its customers with optimal pricing and support. Chembio also then intends to pursue Over-the-Counter (OTC) approval of this product. The regulatory pathway for OTC approval was significantly clarified on November 17, 2009 by the FDA's Blood Products Advisory Committee.
Lawrence Siebert, Chembio's Chief Executive Officer, commented, "We are very pleased with the performance of our product in these studies and our USAID approval. Complemented by our patent-pending oral fluid collection system and 24-month room temperature stability, we believe our DPP® oral fluid HIV test can have a significant impact on HIV prevention efforts globally."
Mr. Siebert continued, "We believe that there is a significant market opportunity for our oral fluid HIV test in the U.S. Although oral fluid HIV testing is not as well established internationally compared to the U.S., we believe this is in part because until now there has not been a product that has the performance, convenience, flexibility, stability and pricing features required to serve these markets."
The DPP® Oral HIV 1&2 Screen Assay is a simple point-of-care diagnostic test for the detection of antibodies to HIV 1&2 which incorporates Chembio's patented dual path platform (DPP®) rapid diagnostic test technology. It provides the convenience and flexibility of being equally accurate with blood matrices as with oral fluid samples, and uses a similar procedure in all cases. The oral fluid sample is collected by means of a separate oral fluid swab collection system. This patent-pending system provides a convenient closed system for the preparation and storage of the sample solution prior to its being applied to the test strip. Chembio's patented DPP® point-of-care technology allows for the incubation of samples with the capture reagents on a test strip before introduction of the labeling reagent, thereby allowing for a more sensitive binding reaction to take place between the sample and capture reagent(s). Data show that this achieves more consistent results than oral fluid tests that utilize lateral flow technology, which must mix viscous oral fluid samples with labeling reagents before the reaction with the capture reagent(s) can occur. The Chembio collection system also enables users the option (with oral fluid or blood samples) to store samples before the test is run for extended periods, and/or to retain samples for further testing.
The DPP® Syphilis Screen & Confirm rapid test is the first simple rapid test which can detect the two markers (treponemal and non-treponemal) that must be present in order to confirm that there is an active, untreated case of syphilis. Although there is no assurance, regulatory clearance for this product is being planned for 2011.
Information about the HIV Testing Conference can be viewed at: http://www.hivtestingconference.org/.
About Chembio Diagnostics
Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $7 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by Inverness Medical Innovations, Inc. Chembio markets its HIV STAT-PAK® line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP®) technology, which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP®. Headquartered in Medford, NY, with approximately 100 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U. S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485.
Forward-Looking Statements
Statements contained herein that are not historical facts may be forward-looking statements within the meaning of the Securities Act of 1933, as amended. Forward-looking statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements are estimates only, as the Company has not completed the preparation of its financial statements for those periods, nor has its auditor completed a review or audit of those results. Actual revenue may differ materially from those anticipated in this press release. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to Chembio's ability to obtain additional financing, to obtain regulatory approvals in a timely manner and the demand for Chembio's products. Chembio undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in Chembio's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact Chembio's success are more fully disclosed in Chembio's most recent public filings with the U.S. Securities and Exchange Commission.
Contact:
Contacts:Company: Contact:Susan Norcott 631-924-1135 x125 or snorcott@chembio.com Investor & Public RelationsThe Investor Relations Group212-825-3210James Carbonara mailto:JCarbonara@irgnvestorrelationsgroup.com
"Cyclone cannot put out a press release every time there is a delay..or every time something good happens...it is time consuming and costly..."
Yes, but they could have come clean in their last letter to the shareholders. They tout their deals and hold back any information that reflects their problems. Given their non-disclosure on Bent Glass can you truly say that things are going well with other deals on the table? This type of lack of transparency will begin to haunt them as shareholders leave and it requires more and more dilution to continue to fund their R&D. If management has any respect for you, you may want to give them a nudge towards being a more responsible public company.
LDPP --LONDON PACIFIC & PARTNERS, INC. (PINK SHEETS:LDPP - News) (“London Pacific” or the “Company”), the international investment and management advisor, announced on Friday, February 12, its results for the fourth quarter ended December 31, 2009. Net revenue for the fourth quarter was $325,276 and pre-tax profit was $72,076. This compares to net revenue of $128,962 and pre-tax profit of $2,318 in the fourth quarter ended December 31, 2008, representing year-on-year increases of 152% in net revenue and 3,009% in pre-tax profit for the quarter.
Commenting on the fourth quarter results, Stuart Bruck, Executive Chairman of London Pacific, said, “I am very pleased with the consistent financial performance of the Company and look forward to the fruition of several transactions and management engagements in progress, including the recently announced (January 20, 2010) agreement to acquire an established, profitable and growing healthcare system in Brazil. The Company plans to continue to identify and act upon cash-generative opportunities that are focused on healthcare, hospitality and financial services.”
About London Pacific & Partners, Inc.:
With offices in Los Angeles, Salt Lake City, London and Mumbai, London Pacific & Partners, Inc. is an international private equity and corporate finance investor and advisor focused on the transformation of undervalued and growth companies in the healthcare, hospitality, and financial services sectors. The Company’s website address is http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.londonpacificgroup.com&esheet=6178392&lan=en_US&anchor=www.londonpacificgroup.com&index=1&md5=55a6d377b72360a427b7a0c47023429e.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, and the impact of competitive services and pricing and general economic risks and uncertainties.
Contact:
London Pacific & Partners, Inc.Michael Low, 310-531-8226info@londonpacificgroup.com
Sounds like you need a new bird, lol.
Well, if you just believe that it is hopeless then that "draggin' things on" feeling will go away.
Well, at least we know that is not the case now since there is no way to buy or sell this stock. I figure that it is already ended and that I am already a bagholder. It's just fun coming back to this board to see you folks and to see if there is such a thing as magic and if tinker bell does exist.
It's a funny one. I think they will uplist sometime this year and then it will become noticed. I'm just kicking back and waiting on this one. It's not too much money to own a few thousand shares on the chance that it breaks out and becomes a thriving company. Brazil is not a bad place to be doing business.
London Pacific & Partners Affiliate Signs Agreement to Acquire Regional Healthcare System in Brazil Foundation for Larger Brazilian Healthcare Strategy
EL SEGUNDO, Calif.--(BUSINESS WIRE)--LONDON PACIFIC & PARTNERS, INC. (PINK SHEETS:LDPP - News) (FRANKFURT:EGU - News) (“London Pacific” or the “Company”), the international advisory and investment firm, today announced that LP Healthcare Group, LLC (“LPHC”), a joint venture between London Pacific and Incite Financial, LLC, has signed an agreement to acquire Santos Administraçao e Participações S.A. (“Santos”) — a regional healthcare system including a 125,000-member health maintenance organization (HMO) , three hospitals with a total of 290-beds, three full-service primary care centers and other related interests in the state of Sao Paulo, Brazil. The three hospitals include a 250-bed comprehensive regional hospital and two local hospitals.
LPHC has agreed to acquire a 100% controlling interest in Santos which owns 100% of the HMO and a 57.4% controlling interest in the hospitals and primary care centers and other related interests for $50 million in cash.
London Pacific presently owns 30% of LPHC with an option to acquire an additional 20% ownership and will manage the healthcare system via a long-term contract.
Santos, a 53 year old healthcare system headquartered in a rapidly growing coastal region of the state of Sao Paulo in southeastern Brazil, generated approximately $173 million in revenues and $23 million in EBITDAR (earnings before interest, taxes, depreciation and rentals) for the year ended December 31, 2009. The system is currently undergoing an aggressive expansion and modernization program.
In addition to providing advisory and management services, London Pacific also participates as a principal in acquisitive transactions such as the purchase of Santos. The Company utilizes its own cash and securities to facilitate such transactions or secures investment capital from strategic partners or financial institutions. LPHC was organized by London Pacific as a special-purpose acquisition vehicle to acquire Santos.
Closing of the acquisition is expected in the first quarter of 2010. The Company intends to maintain Santos’ current operational management team.
Stuart Bruck, Executive Chairman of the Company, stated: “The acquisition of Santos will represent a watershed in the development of London Pacific. Our experience in healthcare services, development and management should help Santos achieve greater long term growth and profitability. In addition, we intend to leverage our presence in Brazil to acquire additional healthcare properties in the region, as well as look for strategic opportunities for hospitality and natural resources investments and projects which fit our Company profile.”
About London Pacific:
With offices in Los Angeles/Salt Lake City, London and Mumbai, London Pacific & Partners, Inc. is an international advisory and investment firm, specializing in healthcare, hospitality, and natural resources. The Company’s website address is www.londonpacificgroup.com.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, and the impact of competitive services and pricing and general economic risks and uncertainties.
Contact:
London Pacific & Partners, Inc.Michael Low, Senior Managing Director310-531-8226ir@londonpacificgroup.com
Thanks for the info. From a person who is sensitive to noise, I think emergency use will be the bigger market potentially. I look forward to see what comes out for the homeowner and may buy my first generator if it is affordable and all that it says it can be (multifuels, etc.). Actually, I look forward to anything coming out to the market at anytime as this wait puts the company in more dire financial straits. Of course, that is why they are a public company and they will need to dilute for a period of time that we hope is not too long or too diluitive. Hopefully, they give us an annual update on their share count this month on pink sheets.
LDPP - LONDON PACIFIC & PARTNERS, INC. (PINK SHEETS:LDPP - News) (FRANKFURT:EGU - News) (“London Pacific” or the “Company”), the international advisory and investment firm, today announced that LP Healthcare Group, LLC (“LPHC”), a joint venture between London Pacific and Incite Financial, LLC, has signed an agreement to acquire Santos Administraçao e Participações S.A. (“Santos”) — a regional healthcare system including a 125,000-member health maintenance organization (HMO) , three hospitals with a total of 290-beds, three full-service primary care centers and other related interests in the state of Sao Paulo, Brazil. The three hospitals include a 250-bed comprehensive regional hospital and two local hospitals.
LPHC has agreed to acquire a 100% controlling interest in Santos which owns 100% of the HMO and a 57.4% controlling interest in the hospitals and primary care centers and other related interests for $50 million in cash.
London Pacific presently owns 30% of LPHC with an option to acquire an additional 20% ownership and will manage the healthcare system via a long-term contract.
Santos, a 53 year old healthcare system headquartered in a rapidly growing coastal region of the state of Sao Paulo in southeastern Brazil, generated approximately $173 million in revenues and $23 million in EBITDAR (earnings before interest, taxes, depreciation and rentals) for the year ended December 31, 2009. The system is currently undergoing an aggressive expansion and modernization program.
In addition to providing advisory and management services, London Pacific also participates as a principal in acquisitive transactions such as the purchase of Santos. The Company utilizes its own cash and securities to facilitate such transactions or secures investment capital from strategic partners or financial institutions. LPHC was organized by London Pacific as a special-purpose acquisition vehicle to acquire Santos.
Closing of the acquisition is expected in the first quarter of 2010. The Company intends to maintain Santos’ current operational management team.
Stuart Bruck, Executive Chairman of the Company, stated: “The acquisition of Santos will represent a watershed in the development of London Pacific. Our experience in healthcare services, development and management should help Santos achieve greater long term growth and profitability. In addition, we intend to leverage our presence in Brazil to acquire additional healthcare properties in the region, as well as look for strategic opportunities for hospitality and natural resources investments and projects which fit our Company profile.”
About London Pacific:
With offices in Los Angeles/Salt Lake City, London and Mumbai, London Pacific & Partners, Inc. is an international advisory and investment firm, specializing in healthcare, hospitality, and natural resources. The Company’s website address is www.londonpacificgroup.com.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, and the impact of competitive services and pricing and general economic risks and uncertainties.
Contact:
London Pacific & Partners, Inc.Michael Low, Senior Managing Director310-531-8226ir@londonpacificgroup.com
I think home power generation during power outages would be a premier point of use for cypw technology. Personally, I wish they would put more focus in this area.
Happy New Year all, just checking in as I didn't dump my shares for tax losses last year ... what the hell. Hey, at least we have each other .. lol.
Me neither grajekk, learn something every day (but forget more the older I get). Happy New Year to All and see you in 2010.
rags
This is a good one, congrats to the company and glta .. eom
PRESS RELEASE
Cyclone Power Technologies Finalizes License
To Manufacture Engine Systems for China Market
POMPANO BEACH, FL, Dec. 17, 2009. Cyclone Power Technologies Inc. (Pink Sheets: CYPW) has completed its License Agreement with Great Wall Alternative Power Systems Ltd. to advance the development and production of Cyclone's Schoell Cycle heat-regenerative external combustion engines for the China market.
Under the terms of the License, Great Wall Alternative Power Systems (GWAPS) will develop in China a production prototype of Cyclone's biomass-to-power generator system - a portable power plant capable of producing 10kW or more of electricity from the combustion of dry vegetative biomass. Pending completion of production prototyping for Cyclone's Mark V engine in the United States, as well as successful implementation of the intellectual property protection systems in China designed by both GWAPS and Cyclone, GWAPS will also develop the larger 95hp Mark V engine for electric power production by late 2010.
GWAPS has agreed to pay Cyclone $125,000 in development fees, an additional $400,000 in licensing fees, and then on-going royalties from the sale of Cyclone engines for use in electric power production in China. Engine systems other than biomass-to-power and the Mark V for non-motive power applications would require added development and license fees. Additionally, GWAPS will invest capital to provide for legal and financial structuring, government outreach, and intellectual property protection, including retaining professional organizations to monitor and, if necessary, prosecute patent infringement cases in China. Cyclone has also retained legal counsel in China to audit the IP protocols that GWAPS establishes.
"The protection of our technology in China is a critical component of this license," stated Cyclone COO, Frankie Fruge. "We have spoken with many of our shareholders after the announcement of our letter of intent with GWAPS, and have implemented some very strong procedures to secure our intellectual property. But in the end, it is the quality and character of one's partners in China that matters the most, and with the Great Wall team, we feel very confident in their integrity, professionalism and engineering abilities to get our engines to market quickly."
Robert Devine, Managing Director of GWAPS, said, "Great Wall Alternative Power Systems sees this innovative biomass-to-power generator system as the first piece in a long and fruitful working relationship with Cyclone Power. The Chinese government has set an installed capacity target of 30GW of biomass-generated power by 2020, with expected investment approaching US$30 billion. If Cyclone and GWAPS can deliver the first reliable, cost-effective distributed biomass power solution as part of this rollout, the market is basically endless."
GWAPS was formed by a group of veteran China operators and investors for the purpose of developing Cyclone technologies for the China market. GWAPS Chairman Zhan Shan, a PRC national, previously founded several new energy ventures including China's first private municipal gas company as well as China's first technology developer of large-format lithium-ion batteries. Managing Director Robert Devine has over a decade's experience investing in the PRC's consumer goods, technology, media and real estate sectors, initially with a well-known US private equity group then later on his own account. Keith McDade, recruited from the US to be VP of Technology and Engineering, has a 20-year successful track record in engine systems engineering and management with companies such as Boeing, Pratt & Whitney and Airbus. Keith also has previous work experience in China.
"We see great potential for capturing an enormous market for our engines and establishing a solid foundation for IP protection," added Ms. Fruge. "We are very pleased to be working with Shan, Robert, Keith and the rest of the Great Wall team."
CORPORATE PROFILE
Cyclone Power Technologies is the developer of the award-winning Cyclone Engine - an eco-friendly external combustion engine with the power and versatility to run everything from portable electric generators and garden equipment to cars, trucks and locomotives. Invented by company founder and CEO Harry Schoell, the patented Cyclone Engine is a modern day steam engine, ingeniously designed to achieve high thermal efficiencies through a compact heat-regenerative process, and to run on virtually any fuel - including bio-diesels, syngas or solar - while emitting fewer greenhouse gases and irritating pollutants into the air. Currently in its late stages of development, the Cyclone Engine was recognized by Popular Science Magazine as the Invention of the Year for 2008, and was presented with the Society of Automotive Engineers' AEI Tech Award in 2006 and 2008. Additionally, Cyclone was recently named Environmental Business of the Year by the Broward County Environmental Protection Department. For more information, visit www.cyclonepower.com.
Media Contact
Will Wellons
407-462-2718
will@wellonscommunications.com
Company Contact:
Frankie Fruge
954-943-8721
Frankie@cyclonepower.com
Safe Harbor Statement
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The company cautions that these forward-looking statements are further qualified by other factors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
Good luck MZEI, hope you brought some good mojo with you. I'm a bit pissed at the company for the moment but still holding shares as the promise is still there. However, I feel the risk has gone up a bit if they have failed at BG ... maybe Spain and China will be the company's first sources of retail revenue. Kat says they haven't failed at BG yet, so will wait to see.
They PR'd Bent Glass when it was good for them, they know people are waiting for it to go on-line, yet they don't give a progress report of it in the PR .. is that straight up? It's either an embarrassment or it is going on line in the next few days so they didn't bother, hope it's the latter. I admit that BG is not a huge money maker but it is the first real engine they will have running in the real world and provides a "proof of concept" for future sales. That seems important enough to me to PR their progress. Kat says call them .. you mean they should tell me something that they haven't PR'd to the rest of the investor? I just don't get it, sorry. Here's a bet ... I bet they PR it when it finally does go on-line .. even if it's next year.
No mention of BG, looks like it is toast IMO. A bit disgruntled with the company not giving us an update on that. Shows a lack of integrety and the guts to be up front with shareholders. Maybe one of you folks who have Harry's ear could get the scoop on that or, at least, convince the company that they owe us an explanation. I would have been very understanding given the other achievements and forward looking possibilities but less so now that they seem to want to sweep it under the rug. Makes you think that they will sweep anything they feel untasteful under the rug and hide it from shareholders. That's a far worse red flag than if they just didn't get the BG thing going due to delays that frustrated BG's management.
I agree buenijo, but the longer this goes on the more shares are hitting the market as they fund to modify their engine to overcome real life problems that they are not anticipating in the lab. The sky gets a bit lower then.
Thanks kat, good slant on the idea that I haven't thought about.
LDPP - London Pacific & Partners Reports Strong Q3 2009 Results
EL SEGUNDO, Calif.--(BUSINESS WIRE)--LONDON PACIFIC & PARTNERS, INC. (PINK SHEETS: LDPP - News) (FRANKFURT: EGU - News) (“London Pacific” or the “Company”), the international investment and management advisor, announced on Friday, November 13, its results for the third quarter ended September 30, 2009. Net revenue for the third quarter was $789,865 and pre-tax profit was $225,147. This compares to net revenue of $548,972 and pre-tax profit of $146,876 in the third quarter ended September 30, 2008, representing year-on-year increases of 44% in net revenue and 53% in pre-tax profit for the quarter.
London Pacific recently announced it had successfully changed its name to London Pacific & Partners, Inc. (formerly known as London & Pacific Healthcare, Inc.) and is now trading on the Pink Sheets under its new symbol “LDPP.” The Company also previously announced two key deals: the acquisition of Acadia Group Advisors, an international corporate financier and private equity advisor, and the strategic profit-sharing agreement with Harrell Hospitality Group, a hotel management and investment firm, in which the Company also acquired an exclusive option to purchase Harrell Hospitality within the next four years. These two deals are expected to provide London Pacific with valuable access to high-value transactions and management opportunities in the Corporate Finance and Hospitality sectors, worldwide.
Commenting on the third quarter results, Stuart Bruck, Executive Chairman of London Pacific, said, “I am very pleased with the growth and profitability of our expanding businesses, that now include hospitality and financial services which effectively complements our existing business lines in healthcare and investment banking. With our new company name, increased industry management expertise and addition of seasoned personnel, London Pacific & Partners looks forward to completing a profitable pipeline of material transactions in the months ahead. We anticipate announcing significant milestones in the very near future.”
About London Pacific & Partners, Inc.:
With offices in Los Angeles, Salt Lake City, London and Mumbai, London Pacific & Partners, Inc. is an international private equity and corporate finance investor and advisor focused on the transformation of undervalued and growth companies in the healthcare, hospitality, and financial services sectors. The Company’s website address is www.londonpacificgroup.com.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, and the impact of competitive services and pricing and general economic risks and uncertainties.
Contact:
Acadia Group, Inc.Investor RelationsDana M. Smith310-531-8226ir@acadiagrp.com Buzz up! 0 SendSharePrint
http://finance.yahoo.com/news/London-Pacific-amp-Partners-bw-2154765357.html?x=0&.v=1
OS _ FYI - ~88 million
If it is production ready, why isn't Bent Glass ready? Would like an update on that. Better yet, maybe it will be the next PR telling us it is up and running.
Indeed, China's mantra appears to be "just steal it and do it!". Kind of Nike on steroids. Good for them, bad for everyone else. The US has erectile disfunction when dealing with China. There is only so much and so long we can stick it to them since they own us.
I haven't found anything either. Probably not unusual given the control of the internet China has in their country. I think an important question may be who approached who. Considering Vista's valid concern, I would be most wary if Great Wall approached CYPW and not the other way around (meaning that cypw did their DD and approached a company they wanted to work with). I remain positive but not enough to add to my shares until something comes of it.
I'll send him 1000 shares .. lol